Sarcoidosis Treatment
Total Trials
4
As Lead Sponsor
As Collaborator
0
Total Enrollment
371
NCT04205851
Phase 1 Study With KIN-1901 in Healthy Subjects and Subjects With Ankylosing Spondylitis
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 12, 2019
Completion: Apr 7, 2020
NCT04351243
A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
Phase: Phase 2
Start: Apr 15, 2020
Completion: Apr 1, 2021
NCT05351554
A Study to Assess the Safety, Tolerability, and Efficacy of Namilumab in Participants With Active Cardiac Sarcoidosis
Start: Aug 23, 2022
Completion: Dec 13, 2022
NCT05314517
A Study to Assess the Efficacy and Safety of Namilumab in Participants With Chronic Pulmonary Sarcoidosis
Start: Aug 31, 2022
Completion: Apr 9, 2025
Loading map...